Correction: Phase 2 Study of Pembrolizumab in Patients With Advanced Rare Cancers

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000347corr1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy